AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Characterization of a Functional Test for Mediterranean Family Fever Screening - 2

Recruitingn/aAges 4 Years - anyAllHospices Civils de Lyon
💬

In plain words

What the trial is, and whether it could suit you

Familial Mediterranean fever (FMF) is the most common auto-inflammatory disease (prevalence: 1-5 / 10,000 inhabitants). It is caused by mutations in the MEFV gene, which encodes variants of the Pyrine inflammasome. Inflammasomes are protein complexes of the innate immunity that produce pro-inflammatory cytokines (interleukin-1β). In vitro, our preliminary results demonstrated that the activation of the inflammatory pyrine (measured by the concentration of interleukin-1β) by kinase inhibitors is significantly increased in FMF patients compared to healthy subjects. Furthermore, a measurement of cell death gave significant results in differentiating the patients from the controls. The performance of this functional has been tested, fast and simple diagnostic test on common mutations and wish to assess its characteristics for MEFV mutations. The investigators hypothesize that this quick a

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Children 4 years of age or older or adults * Having a clinical picture compatible with an FMF and a previous genetic analysis finding at least one mutation of the MEFV gene pathogenic or possibly pathogenic for the FMF group; * Newly diagnosed or in the process of follow-up (with no time limit or evolutionary criteria); * During specific or non-specific treatment of the disease or without treatment; * For whom a blood test is planned as part of routine care; * Whose informed non-opposition has been collected (or parental non-opposition in the case of a minor patient); Exclusion Criteria: * Person under legal protection or under the protection of justice or any other protective measures; * Person out of state to express their consent; * Person in emergency situation, vital or not; * Known infections with HIV and / or HBV and / or HCV;
💊

What it tests

  • one additional blood sample during a planned blood test
📍

Where

8 sites
Hôpital Femme-Mère-Enfant
Bron, France
CH de Versailles - Hôpital André Mignot
Le Chesnay, France
Hôpital Edouard Herriot
Lyon, France
Hôpital de la Croix-Rousse
Lyon, France
CHU de Montpellier
Montpellier, France
Service de Pédiatrie - CHU de Nîmes - Hôpital Carémeau
Nîmes, France
Hôpital Tenon
Paris, France
Hôpital Lyon Sud
Pierre-Bénite, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy